PET in natural killer/T-cell lymphoma: the debate continues

Affiliations

¹ Nuclear Medicine Unit, Policlinico S Orsola, Università di Bologna, Bologna 40138, Italy. Electronic address: stefano.fanti@aosp.bo.it.
² Hematology Unit, Policlinico S Orsola, Università di Bologna, Bologna 40138, Italy.

Comment

Stefano Fanti et al. Lancet Haematol. 2015 Feb.

. 2015 Feb;2(2):e50-1.

doi: 10.1016/S2352-3026(15)00004-6. Epub 2015 Jan 28.

¹ Nuclear Medicine Unit, Policlinico S Orsola, Università di Bologna, Bologna 40138, Italy. Electronic address: stefano.fanti@aosp.bo.it.
² Hematology Unit, Policlinico S Orsola, Università di Bologna, Bologna 40138, Italy.

No abstract available

Comment on

Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC, Ko YH, Choi S, Jung SH, Khong PL, Tang T, Yan X, Lim ST, Kwong YL, Kim WS; Asia Lymphoma Study Group. Kim SJ, et al. Lancet Haematol. 2015 Feb;2(2):e66-74. doi: 10.1016/S2352-3026(15)00002-2. Epub 2015 Jan 28. Lancet Haematol. 2015. PMID: 26687611